Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review.
about
J-wave syndromes: Brugada and early repolarization syndromesBrugada Syndrome:Risk Stratification And Management2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theRisk stratification and treatment of brugada syndrome.The Diagnosis, Risk Stratification, and Treatment of Brugada SyndromeFeasibility and outcomes of ajmaline provocation testing for Brugada syndrome in children in a specialist paediatric inherited cardiovascular diseases centreJ-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledgeBeneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada SyndromeBrugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.Quinidine in the treatment of KCNT1-positive epilepsiesAgeing and Brugada syndrome: considerations and recommendations.The genetic component of Brugada syndromeNovel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada SyndromeElectrical storm: recent pathophysiological insights and therapeutic consequences.Brugada syndrome: an update.The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases.Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy.Brugada syndrome in children.Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks.Drug Therapy For Preventing Ventricular Arrhythmia In Brugada syndrome: Do We Have The Answers Yet?From whole exome sequencing to patient-specific therapy: another example of how basic research pays off in patient care.Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy.Low-Dose Quinidine Effectively Reduced Shocks in Brugada Syndrome Patients with an Implantable Cardioverter Defibrillator: A Chinese Case Series Report.A mutant of the Buthus martensii Karsch antitumor-analgesic peptide exhibits reduced inhibition to hNav1.4 and hNav1.5 channels while retaining analgesic activity.Prognosis, risk stratification, and management of asymptomatic individuals with Brugada syndrome: A systematic review.J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.Pharmacological Therapy in Brugada Syndrome.HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
P2860
Q26859366-163970A6-7841-425F-B6DF-9AB27515100CQ28078338-167D29C3-0421-4B35-BCD0-CAA3855CF6A7Q28087002-9CE5285B-C7AA-4C55-963A-34772E0167A5Q33164381-C40A2A65-D84C-4BCE-8A6F-EF7424AD9C68Q33165991-A44CF30C-BB1B-4249-94A5-F0D69F68418DQ34333242-C4375B94-71E7-4B5F-9938-42172E96638DQ34534329-D196E9CF-3D77-4F4B-BACE-0DA1C3E2A5C8Q35781746-35EDF547-19FE-4838-9BE5-37788E07306EQ36534132-8CECC7D2-AFC4-41F7-9C29-7F2DC242A12AQ36739235-EE32E726-DC58-42AA-B5A4-6D4844709652Q36769865-B2082496-4BFE-488C-84AE-E2E690E5BA35Q37011109-B9FF3A71-C912-43CB-BAE7-1D863D65E59DQ37194514-2E0BB421-D5A4-4386-9EF5-1CE137E45E98Q38083549-78592AAE-F435-46C7-8986-5B4CFFA72152Q38086845-8782CE3F-6D74-4941-BD62-25D4E2DED4EAQ38197734-DB9C2C3D-70B2-49B3-B329-A5B06897B22EQ38225937-82FD0A36-C9C9-4057-8901-E91E90D6BF6AQ38316231-5EC12FF5-0C6C-4691-82D8-ACDCDA46A201Q38494265-8840D015-2B46-4E9E-B558-0AC3846E0FC7Q38951641-0BC4F7C6-9817-415D-B7F9-36FBE3591D6CQ41773249-0BB0A3D8-A66E-40DC-97DB-19EBF2902267Q43228080-87152EA5-4A5C-4E5C-AC08-1042113A20E1Q47141806-0902890E-C070-48FB-A919-DD65B24EF4D5Q47670789-C28A2882-AE25-4180-BB19-106A7C6578C6Q47781711-4D444C1C-54B6-4130-B849-372E3B2459EEQ47830325-6824B906-FC23-4CED-A6BA-CC6E0C95C4B1Q55059903-39D29273-4253-4320-95EF-2C1D708FC987Q55415521-00C759F7-A8AF-48EE-A20A-D0527BA06794Q58010282-76AE0904-D418-468D-8B83-C70BE9BECC9F
P2860
Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Long-term efficacy of low dose ...... series and literature review.
@ast
Long-term efficacy of low dose ...... series and literature review.
@en
type
label
Long-term efficacy of low dose ...... series and literature review.
@ast
Long-term efficacy of low dose ...... series and literature review.
@en
prefLabel
Long-term efficacy of low dose ...... series and literature review.
@ast
Long-term efficacy of low dose ...... series and literature review.
@en
P2093
P50
P921
P1433
P1476
Long-term efficacy of low dose ...... e series and literature review
@en
P2093
Aimé Bonny
Antonio De Sisti
Eduardo Hernández-Castillo
Joelci Tonet
Jorge Gómez-Flores
Manuel Cárdenas
Pedro Iturralde
P304
P356
10.1016/J.HRTHM.2012.08.027
P577
2012-08-28T00:00:00Z